Home › Funds › Greenhaven Road Investment Management, L.P. › LFCR
Greenhaven Road Investment Management, L.P. position in LFCR
LIFECORE BIOMEDICAL INC · Health Care
Greenhaven Road Investment Management, L.P. reported holding 2,868,881 shares of LFCR (LIFECORE BIOMEDICAL INC) in its Q3 2026 13F filing — a position valued at US$18.9M, representing 16.25% of its reported portfolio and ranking #1 among its reported holdings. Greenhaven Road Investment Management, L.P. has disclosed LFCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Greenhaven Road Investment Management, L.P.'s LFCR position evolved
Greenhaven Road Investment Management, L.P. first disclosed a stake in LFCR in Q3 2023 at 2,193,333 shares (US$165.5M). Across 13 filings, Greenhaven Road Investment Management, L.P. increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 2,868,881 shares valued at US$18.9M — a reduction of -321,888 shares quarter over quarter.. Notable position changes include a 62% increase in Q4 2024 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.19M | $165.49M | New |
| Q4 2023 | 2.37M | $14.65M | Add |
| Q1 2024 | 2.14M | $11.38M | Reduce |
| Q2 2024 | 2.22M | $11.37M | Add |
| Q3 2024 | 2.23M | $10.99M | Add |
| Q4 2024 | 3.62M | $26.87M | Add |
| Q1 2025 | 3.62M | $25.46M | Hold |
| Q2 2025 | 3.69M | $30.00M | Add |
| Q3 2025 | 3.69M | $27.19M | Hold |
| Q4 2025 | 3.68M | $30.12M | Hold |
| Q1 2026 | 3.54M | $13.16M | Reduce |
| Q2 2026 | 3.19M | $16.75M | Reduce |
| Q3 2026 | 2.87M | $18.88M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LFCR and 13F data
LFCR (LIFECORE BIOMEDICAL INC) is a Health Care company. 20 other funds we track also report a position in LFCR — the largest reported positions include WYNNEFIELD CAPITAL INC (US$24.7M), Legion Partners Asset Management, LLC (US$23.4M), 325 CAPITAL LLC (US$15.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LFCR
- WYNNEFIELD CAPITAL INC 4.70M sh · $24.69M · Q2 2026
- Legion Partners Asset Management, LLC 4.46M sh · $23.42M · Q2 2026
- 325 CAPITAL LLC 2.90M sh · $15.20M · Q2 2026
- DCF Advisers, LLC 376.50K sh · $2.48M · Q3 2026
- WITTENBERG INVESTMENT MANAGEMENT, INC. 314.01K sh · $1.65M · Q2 2026
More on Greenhaven Road Investment Management, L.P.
FAQ
How long has Greenhaven Road Investment Management, L.P. held LFCR?
Greenhaven Road Investment Management, L.P. has disclosed LFCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Greenhaven Road Investment Management, L.P.'s current position in LFCR?
As of Q3 2026, Greenhaven Road Investment Management, L.P. holds 2.87M shares of LFCR (LIFECORE BIOMEDICAL INC), valued at $18.88M, representing 16.25% of its reported portfolio and ranking #1.
Has Greenhaven Road Investment Management, L.P. been buying or selling LFCR?
In the latest 13F filing (Q3 2026), Greenhaven Road Investment Management, L.P. reduced its position in LFCR.
Which other funds hold LFCR?
Other major institutional holders of LFCR include WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, 325 CAPITAL LLC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.